Dopamine Autoreceptor Pharmacology and Function
- 1 January 1997
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatumDevelopmental Brain Research, 1992
- Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatumDevelopmental Brain Research, 1991
- Diminished synaptosomal dopamine (DA) release and DA autoreceptor supersensitivity in schizophreniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- D-2 dopamine autoreceptor selective drugs: Do they really exist?Life Sciences, 1990
- 7-[3-(4-[2,3-dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonistLife Sciences, 1988
- D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMPNeuroscience Letters, 1986
- Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental areaLife Sciences, 1984
- Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI)Life Sciences, 1984
- Dopamine receptor agonists: Intrinsic activity vs. state of receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptorsLife Sciences, 1981